A global hunt for genes that influence heart disease risk has uncovered 157 changes in human DNA that alter the levels of cholesterol and other blood fats – a discovery that could lead to new medications.
Michigan’s top heart and heart surgery program has a new name – the University of Michigan Samuel and Jean Frankel Cardiovascular Center. The change recognizes $50 million in giving from the Samuel and Jean Frankel Foundation.
During Heart Disease Awareness Month, experts at the U-M Cardiovascular Center are available to discuss new strategies for improving patient care and the quality of patients' lives. While cutting-edge techniques are transforming treatment of heart disease, there are ways to prevent getting heart disease in the first place.
The University of Michigan Cardiovascular Center is part of the national Medtronic CoreValve trial to replace diseased valves with a minimally invasive procedure. It's a potentially transformative option for aortic stenosis patients who cannot tolerate open heart surgery.